Lipocine Inc. Quarterly Debt-to-equity in % from Q2 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Lipocine Inc. quarterly Debt-to-equity history and growth rate from Q2 2014 to Q2 2024.
  • Lipocine Inc. Debt-to-equity for the quarter ending June 30, 2024 was 9.34 %, a 62.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 9.34 +3.6 +62.7% Jun 30, 2024
Q1 2024 8.73 +3.18 +57.3% Mar 31, 2024
Q4 2023 8.61 +1.42 +19.8% Dec 31, 2023
Q3 2023 6.89 -2.89 -29.6% Sep 30, 2023
Q2 2023 5.74 -7.95 -58.1% Jun 30, 2023
Q1 2023 5.55 -14.3 -72.1% Mar 31, 2023
Q4 2022 7.19 -14.6 -67% Dec 31, 2022
Q3 2022 9.78 -19.7 -66.8% Sep 30, 2022
Q2 2022 13.7 -23.2 -62.9% Jun 30, 2022
Q1 2022 19.9 -25.6 -56.3% Mar 31, 2022
Q4 2021 21.8 -69.3 -76.1% Dec 31, 2021
Q3 2021 29.5 -90.4 -75.4% Sep 30, 2021
Q2 2021 36.9 -107 -74.3% Jun 30, 2021
Q1 2021 45.5 -112 -71% Mar 31, 2021
Q4 2020 91.1 -29 -24.1% Dec 31, 2020
Q3 2020 120 +14.3 +13.6% Sep 30, 2020
Q2 2020 144 +46 +47.1% Jun 30, 2020
Q1 2020 157 +64.4 +69.4% Mar 31, 2020
Q4 2019 120 +25.9 +27.4% Dec 31, 2019
Q3 2019 106 +34.2 +48% Sep 30, 2019
Q2 2019 97.7 +49.6 +103% Jun 30, 2019
Q1 2019 92.8 +61.2 +194% Mar 31, 2019
Q4 2018 94.3 +79.1 +521% Dec 31, 2018
Q3 2018 71.3 +62.2 +686% Sep 30, 2018
Q2 2018 48.1 +40.3 +515% Jun 30, 2018
Q1 2018 31.6 +24.5 +343% Mar 31, 2018
Q4 2017 15.2 +8.14 +116% Dec 31, 2017
Q3 2017 9.07 +1.35 +17.5% Sep 30, 2017
Q2 2017 7.83 +0.62 +8.61% Jun 30, 2017
Q1 2017 7.14 +1.33 +22.9% Mar 31, 2017
Q4 2016 7.03 +1.81 +34.6% Dec 31, 2016
Q3 2016 7.72 +3.13 +68.2% Sep 30, 2016
Q2 2016 7.2 +2.14 +42.3% Jun 30, 2016
Q1 2016 5.81 -0.08 -1.36% Mar 31, 2016
Q4 2015 5.22 -0.02 -0.38% Dec 31, 2015
Q3 2015 4.59 +0.23 +5.27% Sep 30, 2015
Q2 2015 5.06 +1.13 +28.8% Jun 30, 2015
Q1 2015 5.88 Mar 31, 2015
Q4 2014 5.25 Dec 31, 2014
Q3 2014 4.36 Sep 30, 2014
Q2 2014 3.93 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.